ReviewCurrent oncology (Toronto, Ont.)2021

Current Landscape of Targeted Therapy in Hormone Receptor-Positive and HER2-Negative Breast Cancer.

Samitha Andrahennadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.